1073. Predictors of Vancomycin Switch or Escalation in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection

BACKGROUND: Vancomycin (VAN) is the primary agent for the treatment methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI). VAN is frequently combined with or switched to a second anti-MRSA agent for the treatment of serious BSI because VAN monotherapy has been linked to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagnf, Abdalhamid M, Jorgensen, Sarah, Zasowski, Evan J, Trinh, Trang D, Bhatia, Sahil, Davis, Susan L, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254001/
http://dx.doi.org/10.1093/ofid/ofy210.910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254001/
http://dx.doi.org/10.1093/ofid/ofy210.910

Ejemplares similares